Dihydrocarvyl acetate is a mint-derived monoterpene ester used more often as an aroma chemical than as a pharmacology subject. The strongest live evidence supports its identity, flavor-fragrance use, occurrence in spearmint-related materials, and fragrance safety review rather than standalone therapeutic research. For AromaForge, it should be positioned as a sensory and occurrence marker with relatively thin constituent-specific bioactivity literature and better developed safety-assessment coverage.
Chemical identity and composition
NIST lists dihydrocarvyl acetate as C12H20O2 with CAS 20777-49-5, while PubChem and NIST both connect the broad name to p-menth-8-en-2-yl acetate and related trans stereochemical naming. Archive oil records currently anchor it to trans-dihydrocarvyl acetate in Oregon spearmint.
Aroma and practical use
- Use the recorded floral, minty, sweet, rose-like, camphoreous, camphoraceous descriptors to explore a blend's scent character; perceived strength also depends on the other ingredients.
- Review the flagged use concerns across every contributing oil and the selected dilution.
- Read the route, preparation and experimental context before using a study finding to choose an oil.
Reported benefits and effects
Findings retain their study context. An animal or laboratory result describes that experiment.
sweet lemon mint occurrence
A 2022 full-text Mentha survey found cis-dihydrocarvone and dihydrocarvyl acetate as the main components of Mentha dulcia citreus 'Hillary's Sweet Lemon', with dihydrocarvyl acetate reported at 13.01% in that taxon.
Measured: major-compound identification in one mint taxon
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
spearmint terpenoid marker
A 2022 spearmint phytochemical study included dihydrocarvyl acetate among the terpenoids commonly present in Mentha spicata extracts and essential-oil-related fractions, supporting its relevance as a minor spearmint marker rather than a universal dominant constituent.
Measured: detection among spearmint terpenoids commonly present in extracted fractions
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Use concerns and concentration limits
Sensitization concernFlagged
Flagged in the constituent reference; assess the source, route and finished-product concentration.
Phototoxicity concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Oxidation concernNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
Penetration enhancementNot flagged
Not flagged in the current model. This is not proof of absence or unrestricted safety.
A recorded constituent reference, not a recommended oil dilution. Product category, source applicability and all contributing oils must be checked before use.
unverified reference · No source provenance attachedPubMed search results and The Good Scents safety summary both indicate that dihydrocarvyl acetate has a published RIFM fragrance ingredient safety assessment.
The source assessment applies to its specified exposure and preparation; this entry is not an unrestricted-use clearance.
The Good Scents summary reviewed in this pass reports no irritation or sensitization in a 4% human-experience listing, oral and dermal rat LD50 values above 5000 mg/kg, and an IFRA-linked recommendation up to 8% in fragrance concentrate.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
No strong constituent-specific human efficacy literature was verified in this pass, and safety interpretation here should remain limited to fragrance/flavor review context rather than broad use claims.
This reference does not establish a therapeutic result or a safe use level for a custom oil blend.
Constituents it may interact with
No constituent-pair interaction is recorded for this identity. The report does not assume either amplification or incompatibility.
What this report cannot establish
- A reported constituent percentage does not establish an effective human therapeutic dose or the amount absorbed into the body.
- The presence of a constituent does not guarantee a clinical benefit, rash treatment or sleep improvement from a custom blend.
- An unflagged concern or missing use limit does not establish safety for ingestion, inhalation, skin exposure or a particular person.
- A candidate constituent interaction does not establish that two oils amplify one another at the selected proportions.
- Constituent descriptors alone do not establish a precise top, heart or base lifetime in a finished blend.
Known data gaps (5)
- The public evidence located here supports occurrence, aroma use, and safety assessment more strongly than isolated pharmacology.
- The broad name dihydrocarvyl acetate is used alongside trans- and other stereochemical naming in databases and oil literature.
- No constituent-specific human clinical studies were verified in this pass.
- The numeric dermal reference lacks source provenance; a verified flag alone is insufficient.
- Some findings do not record an explicit exposure route; consult the linked study before applying them to a use.